Home » Topics » BioWorld Science

BioWorld Science
RSS

TrovaGene completes second dosing cohort in phase Ib/II study of onvansertib in AML

Aug. 17, 2018

Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip

Aug. 17, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

Sihuan Pharmaceutical begins phase II study of pirotinib

Aug. 17, 2018

Development of novel broad coverage human papilloma virus vaccines

Aug. 17, 2018

Metabolism targeting compound kills brain tumor cells

Aug. 17, 2018

Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment

Aug. 17, 2018

First patient dosed in Inovio's phase I/II study of Pennvax-GP

Aug. 17, 2018

Targeted drug delivery using humanized Sialyl Tn-specific antibodies for ovarian cancer treatment

Aug. 17, 2018

MicroRNA affects neuropathic pain

Aug. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...